
ALC Stock Forecast & Price Target
ALC Analyst Ratings
Bulls say
Alcon is well-positioned in the vision care industry due to its diverse product offerings in both the visioncare and surgical segments. The company has a strong market share in the contact lens and cataract surgery markets, with successful product launches for both segments. Management also has a strategic focus on expanding the company's presence in emerging markets, which could drive future growth. In addition, the company's recent spin-off from Novartis allows it to focus solely on its vision care business, providing potential for better operational efficiency and growth opportunities.
Bears say
Alcon is currently experiencing stable growth in its contact lens and surgical segments, driven by new product contributions. However, market growth is expected to remain subdued at 3-4%, with potential risks of market share losses and slower margin improvement. Additionally, concerns over tougher comps in the second half of FY26 and increased operating spending may weigh on profitability. The success of ALC's top-line growth and cost management strategies will be key factors in determining its future performance.
This aggregate rating is based on analysts' research of Alcon Inc. - Registered Shares and is not a guaranteed prediction by Public.com or investment advice.
ALC Analyst Forecast & Price Prediction
Start investing in ALC
Order type
Buy in
Order amount
Est. shares
0 shares